Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

VoxCell BioInnovation

VoxCell BioInnovation makes vascularized cancer tissue models for the drug development industry and oncology research
2020
Nov-50
11-50
Victoria, Canada
  • Drug Discovery and Development
  • Oncology (Cancer)
  • Pathology & Diagnostics
  • Personalized Medicine Technologies

Innovation

Industry Problem

Conventional tumor models often lack realistic vasculature and tissue architecture, reducing their predictive value in drug development.

R&D Focus

Vascularized 3D human tissue models, bioinks and oncology drug testing.

Innovative Solution

Creates bioprinted tissue models with perfusable vascular features for oncology research and preclinical testing.

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

$1.7M

Last Funding Date

01-01-2023

Startup Stage

Early Stage

Lead Investors

Creative Destruction Lab, Adara Ventures, Archangel Network of Funds, Boost Capital, Cindicates

People

Founders

CEO

About

VoxCell BioInnovation makes vascularized cancer tissue models for the drug development industry and oncology research

Products

Product

Universal Bioink Kits and vascularized cancer tissue-model services.

Star Product

Vascularized oncology tissue model, because it addresses the company’s main goal of improving preclinical drug prediction.

Demo Product or Complete Product?

Research-use tissue-model services and bioink products are available; advanced models continue to be developed.

M&A and Collabs

Collab

Altasciences: strategic collaboration to integrate vascularized tissue models into preclinical development.

Collab

Academic and biopharma partners: validation of tissue models and testing workflows.

Something missing or incorrect on this page? Help us enrich this information